<DOC>
	<DOC>NCT02079818</DOC>
	<brief_summary>The primary objective of this study is to gather post market data on the Penumbra Ruby Coil System in the treatment of visceral artery aneurysms and arteriovenous malformations. This study is a prospective, multi-center study of patients with visceral artery aneurysms and visceral arteriovenous malformations who are treated by the Penumbra Ruby Coil System. Data for each patient are collected up to 12 months post-procedure for the study.</brief_summary>
	<brief_title>Visceral Artery Aneurysm Embolization by the Penumbra Rubyâ„¢ Coil System</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Arteriovenous Malformations</mesh_term>
	<mesh_term>Hemangioma</mesh_term>
	<criteria>Patients enrolled in this study must be those treated according to the cleared indication for the Penumbra Ruby Coil System for visceral arterial and venous embolizations. Patients in whom endovascular embolization therapies other than Penumbra Coils are used will be excluded from this study.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>visceral artery aneurysms</keyword>
	<keyword>arteriovenous malformations</keyword>
	<keyword>Penumbra Ruby Coil System</keyword>
</DOC>